Socialiya - Entertainment. Knowledge. Community.
ASCO: Celcuity dares to dream of becoming $10B company after breast cancer win over Piqray

Celcuity hopes its PAM pathway inhibitor gedatolisib can power its growth into the next biotech supe...

BUSINESS NEWS June 02, 2026

ASCO: Celcuity dares to dream of becoming $10B company after breast cancer win over Piqray

Celcuity hopes its PAM pathway inhibitor gedatolisib can power its growth into the next biotech superstar.

2 views 0 likes 0 comments
Share:
Celcuity hopes its PAM pathway inhibitor gedatolisib can power its growth into the next biotech superstar.

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya